The clinical outcome of pazopanib treatment for soft tissue sarcomas: A Japanese Musculoskeletal Oncology Group study

被引：0
|
作者：
Matsumine, Akihiko [1 ]
Nakamura, Tomoki [1 ]
Kawai, Akira [2 ]
Araki, Nobuhito [3 ]
Goto, Takahiro [4 ]
Yonemoto, Tsukasa [5 ]
Sugiura, Hideshi [6 ]
Nishida, Yoshihiro [7 ]
Hiraga, Hiroaki [8 ]
Ueda, Takafumi [9 ]
机构：
[1] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan
[2] Natl Canc Ctr, Div Orthopaed Surg, Tokyo, Japan
[3] Osaka Gen Med Ctr, Dept Orthopaed Surg, Osaka, Japan
[4] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Orthopaed Surg & Musculoskeletal Oncol, Tokyo, Japan
[5] Chiba Canc Ctr, Div Orthoped Surg, Chiba, Japan
[6] Nagoya Univ, Grad Sch Med, Dept Phys Therapy, Nagoya, Aichi, Japan
[7] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi, Japan
[8] Hokkaido Canc Ctr, Dept Orthoped Surg, Sapporo, Hokkaido, Japan
[9] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-13-3
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study
    Nakamura, Tomoki
    Matsumine, Akihiko
    Kawai, Akira
    Araki, Nobuhito
    Goto, Takahiro
    Yonemoto, Tsukasa
    Sugiura, Hideshi
    Nishida, Yoshihiro
    Hiraga, Hiroaki
    Honoki, Kanya
    Yasuda, Taketoshi
    Boku, Shogen
    Sudo, Akihiro
    Ueda, Takafumi
    CANCER, 2016, 122 (09) : 1408 - 1416
  • [2] The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study
    Tomoki Nakamura
    Satoshi Tsukushi
    Kunihiro Asanuma
    Hirohisa Katagiri
    Kunihiro Ikuta
    Akihito Nagano
    Eiji Kozawa
    Satoshi Yamada
    Yoji Shido
    Kenji Yamada
    Katsuhisa Kawanami
    Daisuke Ishimura
    Akihiro Sudo
    Yoshihiro Nishida
    Clinical & Experimental Metastasis, 2019, 36 : 343 - 350
  • [3] Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study
    Urakawa, Hiroshi
    Kawai, Akira
    Goto, Takahiro
    Hiraga, Hiroaki
    Ozaki, Toshifumi
    Tsuchiya, Hiroyuki
    Nakayama, Robert
    Naka, Norifumi
    Matsumoto, Yoshihiro
    Kobayashi, Eisuke
    Okuma, Tomotake
    Kunisada, Toshiyuki
    Ando, Masahiko
    Ueda, Takafumi
    Nishida, Yoshihiro
    CANCER SCIENCE, 2020, 111 (09) : 3303 - 3312
  • [4] The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study
    Nakamura, Tomoki
    Tsukushi, Satoshi
    Asanuma, Kunihiro
    Katagiri, Hirohisa
    Ikuta, Kunihiro
    Nagano, Akihito
    Kozawa, Eiji
    Yamada, Satoshi
    Shido, Yoji
    Yamada, Kenji
    Kawanami, Katsuhisa
    Ishimura, Daisuke
    Sudo, Akihiro
    Nishida, Yoshihiro
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (04) : 343 - 350
  • [5] Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study
    Yoneda, Y.
    Kunisada, T.
    Naka, N.
    Nishida, Y.
    Kawai, A.
    Morii, T.
    Takeda, K.
    Hasei, J.
    Yamakawa, Y.
    Ozaki, T.
    EJSO, 2014, 40 (01): : 49 - 54
  • [6] Surgical treatment of musculoskeletal soft tissue sarcomas
    Rudert, M.
    Burgkart, R.
    Gradinger, R.
    Rechl, H.
    CHIRURG, 2009, 80 (03): : 194 - 201
  • [7] Pazopanib in advanced soft tissue sarcomas
    Lee, Alex T. J.
    Jones, Robin L.
    Huang, Paul H.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4
  • [8] Pazopanib in advanced soft tissue sarcomas
    Alex T. J. Lee
    Robin L. Jones
    Paul H. Huang
    Signal Transduction and Targeted Therapy, 4
  • [9] Early metabolic response as predictor for treatment outcome of pazopanib in patients with metastatic soft tissue sarcomas (the PREDICT study).
    Van Der Graaf, Winette T. A.
    Vlenterie, Myrella
    Steeghs, Neeltje
    Desar, Ingrid
    Verheijen, Remy B.
    Koenen, Anne Miek
    Grootjans, Willem
    de Geus-Oei, Lioe-Fee
    Oyen, Wim J. G.
    Van Erp, Nielka P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Pazopanib: a promising new agent in the treatment of soft tissue sarcomas
    Kasper, Bernd
    Hohenberger, Peter
    FUTURE ONCOLOGY, 2011, 7 (12) : 1373 - 1383
12345